Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study)
| Autor: | Orbach, D., Carton, M., Khadir, S.K., Feuilly, M., Kurtinecz, M., Phil, D., Vokuhl, C., Koscielniak, E., Pierron, G., Lemelle, L., Sparber-Sauer, M. |
|---|---|
| Zdroj: | In ESMO Open May 2024 9(5) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|